{"hands_on_practices": [{"introduction": "A cornerstone of engineering mammalian cells for therapeutic applications is the careful design of the delivery vehicle. Viral vectors, like the Adeno-Associated Virus (AAV), are powerful tools, but they come with a strict physical constraint: a limited packaging capacity. This exercise [@problem_id:2733893] challenges you to think like a vector engineer, performing a fundamental \"cargo budget\" calculation to determine the maximum size of a therapeutic gene that can be loaded into an AAV vector, a critical first step in the design of any gene therapy construct.", "problem": "You are engineering an Adeno-Associated Virus (AAV) vector to deliver a therapeutic transgene to Human Embryonic Kidney 293 (HEK293) cells. The AAV capsid imposes a hard packaging constraint on the total length of the single-stranded vector genome that can be encapsidated. This total packaged genome comprises all required cis-acting elements, including the two Inverted Terminal Repeats (ITRs), and all expression cassette components such as promoters, enhancers, untranslated regions (UTRs), polyadenylation signals, and the coding sequence (CDS). The engineering design principle is a conservation of total nucleotides: the sum of all component lengths must not exceed the capsid’s maximum packaged genome length. You plan to use a promoter of length $1.2\\,\\text{kb}$, an enhancer of length $0.6\\,\\text{kb}$, and a combined untranslated region plus polyadenylation signal of length $1.0\\,\\text{kb}$. The AAV genome requires ITRs of length $145\\,\\text{bp}$ at each end, and the total AAV packaging limit is $4.7\\,\\text{kb}$ (including ITRs). Assuming all lengths add linearly and must fit within the packaging limit, what is the maximum allowable CDS length that can be accommodated in this vector design? Express your answer in kilobases (kb) and round your answer to three significant figures.", "solution": "The problem statement is scrutinized and found to be valid. It is scientifically grounded in the principles of molecular biology and genetic engineering, specifically concerning the design of Adeno-Associated Virus (AAV) vectors. The parameters provided—such as the packaging limit of approximately $4.7$ kilobases (kb) and the Inverted Terminal Repeat (ITR) length of $145$ base pairs (bp)—are standard and realistic. The problem is well-posed, objective, and contains all necessary information to derive a unique solution through a straightforward calculation.\n\nThe central principle guiding the solution is the conservation of total packaged genome length. The sum of the lengths of all genetic elements to be packaged into the AAV capsid must not exceed the maximum packaging capacity of the capsid. This can be expressed as an equation where the sum of the lengths of all components equals the maximum allowed length.\n\nLet $L_{\\text{max}}$ be the maximum packaging limit of the AAV vector. Let the lengths of the individual components be:\n- $L_{\\text{ITR}}$ for a single Inverted Terminal Repeat.\n- $L_{\\text{P}}$ for the promoter.\n- $L_{\\text{E}}$ for the enhancer.\n- $L_{\\text{UTR+pA}}$ for the combined untranslated region and polyadenylation signal.\n- $L_{\\text{CDS}}$ for the coding sequence.\n\nThe total length of the vector genome, $L_{\\text{total}}$, is the linear sum of all its components. The genome is flanked by two ITRs, so their total length is $2 \\times L_{\\text{ITR}}$. The relationship is:\n$$L_{\\text{total}} = (2 \\times L_{\\text{ITR}}) + L_{\\text{P}} + L_{\\text{E}} + L_{\\text{UTR+pA}} + L_{\\text{CDS}}$$\n\nTo find the maximum allowable CDS length, $L_{\\text{CDS, max}}$, we set the total length equal to the maximum packaging limit:\n$$L_{\\text{max}} = (2 \\times L_{\\text{ITR}}) + L_{\\text{P}} + L_{\\text{E}} + L_{\\text{UTR+pA}} + L_{\\text{CDS, max}}$$\n\nRearranging this equation to solve for $L_{\\text{CDS, max}}$ gives:\n$$L_{\\text{CDS, max}} = L_{\\text{max}} - ((2 \\times L_{\\text{ITR}}) + L_{\\text{P}} + L_{\\text{E}} + L_{\\text{UTR+pA}})$$\n\nThe given values are:\n- $L_{\\text{max}} = 4.7\\,\\text{kb}$\n- $L_{\\text{P}} = 1.2\\,\\text{kb}$\n- $L_{\\text{E}} = 0.6\\,\\text{kb}$\n- $L_{\\text{UTR+pA}} = 1.0\\,\\text{kb}$\n- $L_{\\text{ITR}} = 145\\,\\text{bp}$\n\nA necessary step is to ensure all lengths are in a consistent unit. We will convert all lengths to kilobases (kb), using the conversion factor $1\\,\\text{kb} = 1000\\,\\text{bp}$.\n\nThe length of one ITR is $145\\,\\text{bp}$. The total length of the two ITRs is:\n$$2 \\times L_{\\text{ITR}} = 2 \\times 145\\,\\text{bp} = 290\\,\\text{bp}$$\nConverting this to kilobases:\n$$290\\,\\text{bp} \\times \\frac{1\\,\\text{kb}}{1000\\,\\text{bp}} = 0.290\\,\\text{kb}$$\n\nNow, we can substitute all the values, in kb, into the equation for $L_{\\text{CDS, max}}$:\n$$L_{\\text{CDS, max}} = 4.7 - (0.290 + 1.2 + 0.6 + 1.0)$$\n\nFirst, calculate the sum of the lengths of the non-CDS components:\n$$L_{\\text{non-CDS}} = 0.290\\,\\text{kb} + 1.2\\,\\text{kb} + 0.6\\,\\text{kb} + 1.0\\,\\text{kb} = 3.09\\,\\text{kb}$$\n\nFinally, subtract this sum from the maximum packaging limit to find the maximum allowable CDS length:\n$$L_{\\text{CDS, max}} = 4.7\\,\\text{kb} - 3.09\\,\\text{kb} = 1.61\\,\\text{kb}$$\n\nThe problem requires the answer to be rounded to three significant figures. The calculated value of $1.61$ already has precisely three significant figures ($1$, $6$, and $1$). Therefore, no further rounding is necessary.", "answer": "$$\\boxed{1.61}$$", "id": "2733893"}, {"introduction": "Once a transgene is successfully delivered into a cell, its expression is governed by a dynamic, multi-step process. This practice [@problem_id:2733872] delves into the kinetics of messenger RNA (mRNA) trafficking, using a two-compartment model to explore the flow of genetic information from the nucleus to the cytoplasm. By analyzing the system at steady state, you will uncover a crucial and sometimes counter-intuitive principle: not all \"improvements,\" such as enhancing nuclear export, necessarily lead to an increase in the final cytoplasmic mRNA level, highlighting the importance of identifying the true bottlenecks in a biological pathway.", "problem": "In Human Embryonic Kidney 293 (HEK293) cells, you engineer a synthetic transgene under a constitutive promoter such that nuclear pre-messenger RNA (pre-mRNA) production is approximately constant. You compare two versions of the messenger RNA (mRNA): one intronless and one containing a single intron that enhances nuclear export. Assume a two-compartment model with a nuclear pool and a cytoplasmic pool, first-order nuclear export, negligible nuclear decay, and first-order cytoplasmic decay. The transcription (synthesis) rate is constant at $10$ mRNAs per hour. The cytoplasmic decay rate constant is $0.2$ h$^{-1}$. The intron increases the nuclear export rate constant from $0.1$ h$^{-1}$ (no intron) to $0.5$ h$^{-1}$ (with intron). Assume well-mixed compartments and that steady state is reached in both cases.\n\nStarting from mass balance principles and first-order kinetics, derive the steady-state cytoplasmic mRNA abundance and use it to compute the fold-change in steady-state cytoplasmic mRNA abundance upon adding the intron (defined as the ratio of the steady-state cytoplasmic mRNA with intron to that without intron). Report your final answer as a single dimensionless number. If you obtain a numerical value, do not round unless necessary by the algebraic result.", "solution": "The problem as stated is valid. It is scientifically grounded in standard models of gene expression dynamics, is well-posed with sufficient information for a unique solution, and is expressed in objective, formal language. We will proceed with the solution.\n\nThe problem describes a two-compartment model for mRNA dynamics within a mammalian cell, specifically the nucleus and the cytoplasm. Let $N(t)$ represent the number of mRNA molecules in the nucleus at time $t$, and $C(t)$ represent the number of mRNA molecules in the cytoplasm at time $t$. The dynamics of this system can be described by a set of coupled ordinary differential equations based on mass balance principles.\n\nThe change in the number of nuclear mRNA molecules, $\\frac{dN}{dt}$, is determined by the rate of synthesis (transcription) and the rate of nuclear export.\nThe rate of synthesis is given as a constant, $S$.\nThe rate of nuclear export is modeled as a first-order process, proportional to the nuclear mRNA abundance, with a rate constant $k_{exp}$. Thus, the export rate is $k_{exp} N(t)$.\nThe problem states that nuclear decay is negligible.\nTherefore, the mass balance for the nuclear compartment is:\n$$ \\frac{dN}{dt} = S - k_{exp} N(t) $$\n\nThe change in the number of cytoplasmic mRNA molecules, $\\frac{dC}{dt}$, is determined by the rate of import from the nucleus (which is the nuclear export rate) and the rate of cytoplasmic decay.\nThe rate of import into the cytoplasm is $k_{exp} N(t)$.\nThe rate of cytoplasmic decay is modeled as a first-order process, proportional to the cytoplasmic mRNA abundance, with a rate constant $k_d$. Thus, the decay rate is $k_d C(t)$.\nTherefore, the mass balance for the cytoplasmic compartment is:\n$$ \\frac{dC}{dt} = k_{exp} N(t) - k_d C(t) $$\n\nThe problem requires the analysis at steady state. At steady state, the abundances of mRNA in both compartments are constant over time. This implies that the time derivatives are zero:\n$$ \\frac{dN}{dt} = 0 $$\n$$ \\frac{dC}{dt} = 0 $$\n\nApplying this condition to the system of equations, we obtain a system of algebraic equations for the steady-state abundances, which we denote as $N_{ss}$ and $C_{ss}$.\n\nFrom the nuclear equation:\n$$ 0 = S - k_{exp} N_{ss} \\implies N_{ss} = \\frac{S}{k_{exp}} $$\n\nFrom the cytoplasmic equation:\n$$ 0 = k_{exp} N_{ss} - k_d C_{ss} \\implies k_d C_{ss} = k_{exp} N_{ss} $$\n\nWe can now solve for the steady-state cytoplasmic mRNA abundance, $C_{ss}$. Substituting the expression for $N_{ss}$ from the first equation into the second equation:\n$$ k_d C_{ss} = k_{exp} \\left( \\frac{S}{k_{exp}} \\right) $$\n$$ k_d C_{ss} = S $$\n$$ C_{ss} = \\frac{S}{k_d} $$\n\nThis result is fundamental. It demonstrates that under the specified conditions (notably, negligible nuclear decay and steady state), the cytoplasmic mRNA abundance is determined solely by the synthesis rate $S$ and the cytoplasmic decay rate constant $k_d$. It is independent of the nuclear export rate constant $k_{exp}$. This is because at steady state, the flux of mRNA through the entire pathway must be constant. The rate of synthesis ($S$) must equal the rate of removal from the system, which is exclusively through cytoplasmic decay ($k_d C_{ss}$). The nuclear export rate constant $k_{exp}$ only determines the steady-state partitioning of mRNA between the nucleus and cytoplasm, specifically the nuclear abundance $N_{ss} = S/k_{exp}$, but not the final output of the system, $C_{ss}$.\n\nThe problem asks for the fold-change in steady-state cytoplasmic mRNA abundance upon the addition of an intron. Let us denote the case without the intron as case $1$ and with the intron as case $2$.\n\nThe given parameters are:\nTranscription rate: $S = 10 \\text{ h}^{-1}$ (same for both cases).\nCytoplasmic decay rate constant: $k_d = 0.2 \\text{ h}^{-1}$ (same for both cases).\nNuclear export rate constant without intron: $k_{exp,1} = 0.1 \\text{ h}^{-1}$.\nNuclear export rate constant with intron: $k_{exp,2} = 0.5 \\text{ h}^{-1}$.\n\nLet $C_{ss,1}$ be the steady-state cytoplasmic mRNA abundance without the intron and $C_{ss,2}$ be the abundance with the intron. Using our derived general formula for $C_{ss}$:\n\nFor the case without the intron:\n$$ C_{ss,1} = \\frac{S}{k_d} $$\n\nFor the case with the intron:\n$$ C_{ss,2} = \\frac{S}{k_d} $$\n\nSince $S$ and $k_d$ are the same in both scenarios, it is immediately clear that $C_{ss,1} = C_{ss,2}$.\n\nThe fold-change is defined as the ratio $\\frac{C_{ss,2}}{C_{ss,1}}$.\n$$ \\text{Fold-change} = \\frac{C_{ss,2}}{C_{ss,1}} = \\frac{S/k_d}{S/k_d} = 1 $$\n\nThe fold-change is exactly $1$. The intron alters the nuclear export rate, which changes the steady-state nuclear mRNA abundance ($N_{ss,1} = 10/0.1 = 100$ molecules; $N_{ss,2} = 10/0.5 = 20$ molecules), but it does not affect the steady-state cytoplasmic mRNA abundance under the assumptions of this model. The numerical values provided for the rates are not necessary for the calculation of the fold-change, but they confirm the consistency of the model. In both cases, $C_{ss} = \\frac{10}{0.2} = 50$ molecules. The ratio is $\\frac{50}{50} = 1$.", "answer": "$$\\boxed{1}$$", "id": "2733872"}, {"introduction": "The ultimate goal of many cell engineering projects is to scale up production from a single cell to a large-scale bioreactor. This final practice [@problem_id:2733904] bridges the gap between single-cell behavior and industrial bioprocessing. Using core parameters like specific productivity ($q_P$) and viable cell density, you will learn to estimate the total product yield from a fed-batch culture, a calculation that is fundamental to the design and economic assessment of biomanufacturing processes for therapeutic proteins.", "problem": "A recombinant monoclonal antibody is produced in a fed-batch culture of Chinese Hamster Ovary (CHO) cells. The production phase lasts for $10$ days, during which the working volume is maintained at $2$ liters and the viable cell density is controlled such that its time-average over the production phase is $5 \\times 10^{6}$ cells/mL. The cell-specific productivity is constant at $q_{P} = 20$ pg/cell/day throughout the production phase. Assume $100\\%$ harvest recovery, constant specific productivity, and no product degradation or loss during culture.\n\nUsing only core definitions (for example, that the cell-specific productivity multiplied by the viable cell number gives the instantaneous product formation rate, and that the time integral of this rate over the production phase gives the total mass produced), compute the total mass of product harvested at the end of the production phase. Express your answer in grams and round to three significant figures.", "solution": "We begin from the definition that the instantaneous product formation rate is given by\n$$\n\\frac{dM}{dt} \\;=\\; q_{P} \\, N_{v}(t),\n$$\nwhere $M$ is the accumulated product mass, $q_{P}$ is the cell-specific productivity (in pg/cell/day), and $N_{v}(t)$ is the viable cell number at time $t$. For a culture with viable cell density $X_{v}(t)$ (in cells/mL) and working volume $V$ (in mL), the viable cell number is\n$$\nN_{v}(t) \\;=\\; X_{v}(t)\\, V.\n$$\nAssuming constant working volume, the total mass accumulated over a production phase of duration $T$ is\n$$\nM(T) \\;=\\; \\int_{0}^{T} q_{P}\\,N_{v}(t)\\,dt \\;=\\; q_{P} \\, V \\int_{0}^{T} X_{v}(t)\\,dt.\n$$\nDefine the time-averaged viable cell density over the production phase as\n$$\n\\bar{X}_{v} \\;=\\; \\frac{1}{T} \\int_{0}^{T} X_{v}(t)\\,dt.\n$$\nThen the integral satisfies\n$$\n\\int_{0}^{T} X_{v}(t)\\,dt \\;=\\; \\bar{X}_{v}\\, T,\n$$\nand the mass becomes\n$$\nM(T) \\;=\\; q_{P}\\, V \\, \\bar{X}_{v}\\, T.\n$$\n\nWe are given $V = 2$ liters $= 2000$ mL, $\\bar{X}_{v} = 5 \\times 10^{6}$ cells/mL, $q_{P} = 20$ pg/cell/day, and $T = 10$ days. Substituting,\n$$\nM(T) \\;=\\; \\left(20 \\;\\text{pg/cell/day}\\right)\\, \\left(2000 \\;\\text{mL}\\right)\\, \\left(5 \\times 10^{6} \\;\\text{cells/mL}\\right)\\, \\left(10 \\;\\text{day}\\right).\n$$\nCompute the viable cell number factor:\n$$\nV \\, \\bar{X}_{v} \\;=\\; 2000 \\times 5 \\times 10^{6} \\;=\\; 1 \\times 10^{10} \\;\\text{cells}.\n$$\nThen\n$$\nM(T) \\;=\\; \\left(20 \\;\\text{pg/cell/day}\\right)\\, \\left(1 \\times 10^{10} \\;\\text{cells}\\right)\\, \\left(10 \\;\\text{day}\\right)\n\\;=\\; 2 \\times 10^{12} \\;\\text{pg}.\n$$\nConvert picograms to grams using $1 \\;\\text{g} = 10^{12} \\;\\text{pg}$:\n$$\nM(T) \\;=\\; \\frac{2 \\times 10^{12} \\;\\text{pg}}{10^{12} \\;\\text{pg/g}} \\;=\\; 2 \\;\\text{g}.\n$$\nRounded to three significant figures in grams, the total mass is $2.00$ g.", "answer": "$$\\boxed{2.00}$$", "id": "2733904"}]}